297 related articles for article (PubMed ID: 9696292)
21. Extraorbital giant cell angiofibroma.
Husek K; Veselý K
Cesk Patol; 2002 Jul; 38(3):117-20. PubMed ID: 12325476
[TBL] [Abstract][Full Text] [Related]
22. Histogenetic relations between giant cell fibroblastoma and dermatofibrosarcoma protuberans. CD34 staining showing the spectrum and a simulator.
Harvell JD; Kilpatrick SE; White WL
Am J Dermatopathol; 1998 Aug; 20(4):339-45. PubMed ID: 9700370
[TBL] [Abstract][Full Text] [Related]
23. Giant cell angiofibroma of the orbit and eyelid.
Hayashi N; Borodic G; Karesh JW; Tolentino MJ; Remulla HD; Van Wesep RA; Grossniklaus HE; Jakobiec FA; Green WR
Ophthalmology; 1999 Jun; 106(6):1223-9. PubMed ID: 10366097
[TBL] [Abstract][Full Text] [Related]
24. Composite dermatofibrosarcoma protuberans-giant cell fibroblastoma recurring as Bednár tumor-giant cell fibroblastoma with mucoid lakes and with amputation neuroma.
Zámecník M; Michal M; Chlumská A
Cesk Patol; 2002 Oct; 38(4):173-7. PubMed ID: 12629865
[TBL] [Abstract][Full Text] [Related]
25. Giant cell angiofibroma of the nasolacrimal duct.
Yazici B; Setzen G; Meyer DR; Williams EF; McKenna BJ
Ophthalmic Plast Reconstr Surg; 2001 May; 17(3):202-6. PubMed ID: 11388387
[TBL] [Abstract][Full Text] [Related]
26. Sclerosing dermatofibrosarcoma protuberans.
Diaz-Cascajo C; Weyers W; Borghi S
J Cutan Pathol; 1998 Sep; 25(8):440-4. PubMed ID: 9826170
[TBL] [Abstract][Full Text] [Related]
27. Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation.
Swaby MG; Evans HL; Fletcher CD; Prieto VG; Patel KU; Lev DC; Lòpez-Terrada D; Lazar AJ; Wang WL
Am J Dermatopathol; 2011 Jun; 33(4):354-60. PubMed ID: 21478726
[TBL] [Abstract][Full Text] [Related]
28. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans.
Arican O; Bakaris S; Bulbuloglu E; Ezberci F
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Mar; 15(1):39-44. PubMed ID: 16850098
[TBL] [Abstract][Full Text] [Related]
29. Myxoid dermatofibrohistiocytoma: an indolent post-traumatic tumor composed of CD34+ epithelioid and dendritic cells and factor XIIIa+ dendrophages.
Silverman JS; Brustein S
J Cutan Pathol; 1996 Dec; 23(6):551-7. PubMed ID: 9001986
[TBL] [Abstract][Full Text] [Related]
30. Orbital and extraorbital giant cell angiofibroma: a giant cell-rich variant of solitary fibrous tumor? Clinicopathologic and immunohistochemical analysis of a series in favor of a unifying concept.
Guillou L; Gebhard S; Coindre JM
Am J Surg Pathol; 2000 Jul; 24(7):971-9. PubMed ID: 10895819
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Li N; McNiff J; Hui P; Manfioletti G; Tallini G
Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
[TBL] [Abstract][Full Text] [Related]
32. Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma, and fibrous histiocytoma of the orbit: reappraisal of 41 cases.
Furusato E; Valenzuela IA; Fanburg-Smith JC; Auerbach A; Furusato B; Cameron JD; Rushing EJ
Hum Pathol; 2011 Jan; 42(1):120-8. PubMed ID: 21056898
[TBL] [Abstract][Full Text] [Related]
33. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
[TBL] [Abstract][Full Text] [Related]
34. Fibrosarcomatous dermatofibrosarcoma protuberans with giant rosettes.
Zamecnik M
Am J Dermatopathol; 2001 Feb; 23(1):41-5. PubMed ID: 11176051
[TBL] [Abstract][Full Text] [Related]
35. Sarcomatous dermatofibrosarcoma protuberans metastasized to the lung: preservation of CD34 expression in tumor cells.
Ohtani N; Fukusato T; Tezuka F
Pathol Int; 1998 Dec; 48(12):989-93. PubMed ID: 9952345
[TBL] [Abstract][Full Text] [Related]
36. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
[TBL] [Abstract][Full Text] [Related]
37. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
Abenoza P; Lillemoe T
Am J Dermatopathol; 1993 Oct; 15(5):429-34. PubMed ID: 7694515
[TBL] [Abstract][Full Text] [Related]
38. Comparison of angiomyofibroblastoma and aggressive angiomyxoma in both sexes: four cases composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets.
Zámecník M; Michal M
Pathol Res Pract; 1998; 194(10):736-8. PubMed ID: 9820872
[No Abstract] [Full Text] [Related]
39. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
Goldblum JR; Tuthill RJ
Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
[TBL] [Abstract][Full Text] [Related]
40. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
